current
epidem
coronaviru
declar
global
epidem
epidem
somewhat
similar
previou
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
outbreak
infect
could
trace
zoonot
transmiss
viral
infect
similar
clinic
present
fever
cough
lead
lower
respiratori
tract
diseas
signific
mortal
especi
elderli
underli
health
condit
infect
confirm
nucleic
acid
test
respiratori
tract
sampl
eg
throat
swab
though
initi
clinic
diagnosi
base
symptom
exposur
chest
imag
sinc
specif
effect
antivir
drug
avail
diseas
support
care
paramount
import
studi
show
current
coronaviru
diseas
share
similar
genom
instanc
genom
share
ident
sarscov
ident
bat
coronaviru
batcov
interest
note
angiotensinconvert
enzym
cellular
receptor
sar
coronaviru
sarscov
new
coronaviru
respons
current
epidem
like
coronavirus
particl
spheric
protein
call
spike
protrud
surfac
latch
onto
human
cell
undergo
structur
chang
allow
fuse
cell
membran
figur
facilit
viral
gene
enter
host
cell
copi
produc
virus
report
spike
time
like
bind
human
cell
spike
sar
viru
enabl
spread
easili
person
person
earlier
viru
despit
similar
sequenc
structur
spike
two
virus
three
differ
antibodi
sar
viru
could
success
bind
spike
protein
suggest
potenti
vaccin
antibodybas
treatment
strategi
need
specif
potenti
drug
sar
mer
envelop
positivesens
singlestrand
rna
bcoronaviru
similar
sar
mer
virus
potenti
antivir
target
encod
viral
genom
includ
nonstructur
protein
eg
proteas
papainlik
proteas
rnadepend
rna
polymeras
helicas
structur
protein
eg
capsid
spike
glycoprotein
accessori
protein
sever
clinic
trial
underway
either
alon
variou
combin
interferon
guanosineanalog
rna
synthesi
inhibitor
revers
transcriptas
inhibitor
influenza
drug
baloxavir
marboxil
oseltamivir
umifenovir
investig
drug
remdesivir
nucleotid
analog
antivir
block
rna
polymeras
ebola
viru
investig
potenti
action
noteworthi
least
ten
clinic
trial
test
chloroquin
antimalari
autoimmun
diseas
drug
effect
believ
endosom
acidif
fusion
inhibitori
action
chloroquin
possibl
block
infect
strategi
employ
test
efficaci
drug
clinic
trial
depend
abil
inhibit
key
compon
coronaviru
infect
lifecycl
includ
viral
entri
host
cell
block
umifenovir
chloroquin
interferon
viral
replic
block
lopinavirritonavir
darunavircobicistat
inhibit
proteas
viral
rna
synthesi
inhibit
remdesivir
favipiravir
emtricitabinetenofovir
alafenamid
ribavirin
larg
extent
clinic
trial
depend
high
level
genom
sequenc
similar
sar
mer
protein
involv
replic
cycl
use
angiotensinconvert
enzym
cellular
proteas
transmembran
proteas
serin
enter
target
cell
figur
inhibitor
camostat
mesyl
seem
abil
block
cellular
entri
viru
janusassoci
kinas
jak
inhibitor
olumi
baricitinib
approv
rheumatoid
arthriti
test
basi
capac
inhibit
endocytosi
jak
inhibitor
jakafi
ruxolitinib
clinic
trial
combin
mesenchym
stem
cell
infus
despit
effort
develop
suitabl
effect
drug
take
time
mechan
invad
microorgan
elimin
neutral
includ
gener
specif
antibodi
immunocyt
aid
elimin
elabor
variou
cytokin
reactiv
oxygen
speci
ro
activ
complement
system
specif
nonspecif
mean
trap
kill
littl
injuri
variou
tissu
process
protect
bodi
onslaught
microorgan
could
occur
amount
inevit
inflamm
injuri
celltissu
damag
order
repair
tissu
damag
consequ
attack
invad
organ
result
inflammatori
process
resolut
inflamm
wound
heal
process
need
occur
coordin
orderli
fashion
restor
homeostasi
thu
infect
induc
invad
microorgan
could
local
system
wherea
resolut
inflamm
wound
heal
restor
homeostasi
local
process
event
occur
need
crosstalk
among
invad
organ
tissu
attack
immun
system
inflammatori
event
associ
cell
resolut
initi
induc
cellstissu
molecul
context
noteworthi
polyunsatur
fatti
acid
metabolit
term
bioactiv
lipid
seem
crucial
role
known
staphylococcu
aureu
coagulaseneg
staphylococci
group
streptococci
present
normal
human
skin
render
ineffect
caus
infect
skin
surfac
lipid
especi
unsatur
fatti
acid
group
streptococcu
expos
oleic
acid
oa
die
within
minut
exposur
result
alter
integr
cell
membran
addit
oleic
acid
enrich
mous
periton
macrophag
show
fold
greater
erythrophagocyt
capac
compar
palmit
acidenrich
macrophag
staphylococci
lung
alveoli
kill
mainli
outsid
alveolar
macrophag
seem
resid
highli
unsatur
arachidon
acid
aa
present
surfact
unsatur
fatti
acid
linol
oleic
palmitol
also
show
antibacteri
activ
less
potent
compar
aa
effect
gramposit
gramneg
bacteria
fungi
envelop
virus
includ
influenza
hiv
mechan
antimicrobi
action
aa
fatti
acid
may
includ
abil
induc
leakag
even
lysi
microbi
cell
membran
includ
disrupt
viral
protein
envelop
well
variou
cellular
metabol
effect
includ
limit
inhibit
respiratori
activ
effect
transport
amino
acid
uncoupl
oxid
phosphoryl
base
evid
reason
suggest
alveolar
macrophag
leukocyt
b
cell
nk
cell
immunocyt
releas
aa
unsatur
fatti
acid
surround
milieu
challeng
variou
microorgan
includ
virus
sar
mer
turn
inactiv
invad
organ
thu
protect
lung
tissu
could
one
fundament
mechan
employ
human
bodi
protect
variou
microb
impli
defici
aa
unsatur
fatti
acid
may
render
person
suscept
variou
infect
includ
sar
mer
noteworthi
prostaglandin
leukotrien
thromboxan
form
aa
proinflammatori
action
wherea
lipoxin
aa
resolvin
epa
eicosapentaeno
acid
dha
docosahexaeno
acid
protectin
maresin
deriv
dha
potent
antiinflammatori
action
resolv
inflamm
aid
wound
heal
time
augment
phagocyt
capac
macrophag
cell
remov
debri
site
infect
injuri
enhanc
microbi
clearanc
figur
view
fact
sar
mer
envelop
virus
easili
inactiv
aa
unsatur
fatti
acid
impli
oral
intraven
administr
fatti
acid
may
enhanc
recoveri
infect
present
adequ
amount
immunocyt
bodi
fluid
especi
alveolar
fluid
may
actual
prevent
infect
evid
preced
discuss
aa
unsatur
fatti
acid
inactiv
envelop
virus
includ
sar
mer
metabolit
aa
epa
dha
proand
antiinflammatori
action
particip
resolut
inflamm
wound
heal
regul
phagocyt
action
macrophag
immunocyt
abil
reduc
microbi
load
suggest
aa
epa
dha
antiinflammatori
metabolit
lipoxin
resolvin
protectin
maresin
function
endogen
antimicrobi
molecul
appropri
use
may
aid
decreas
morbid
mortal
due
sar
mer
